Following an excellent presentation at the EAACI Digital Congress 2020, we caught up with Jacklyn Ann Smith (University of Manchester, UK) to discuss the mechanisms of chronic cough and the burden the condition can have on patients.
1.What are the major mechanisms involved in chronic cough? (0:07)
2.Could you tell us little about the physical, social and psychological consequences of chronic cough? (0:47)
3.What are the limitations of the current management of chronic cough in primary care settings? (2:21)
4.What tests do you recommend in the diagnosis and monitoring of chronic cough? (3:22)
5.What advice would you give to allergists regarding optimal treatment of chronic cough? (4:28)
Disclosures: Jaclyn Ann Smith has received grants from Merck, Ario Pharma, GlaxoSmithKline, NeRRe Pharmaceuticals, Menlo, Bellus, and Bayer; personal fees from Chiesi, Ario Pharma, GlaxoSmithKline, NeRRe Pharmaceuticals, Menlo, Bellus, Bayer, Boehringer Ingleheim, Genentech, and Neomed.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the EAACI Digital Congress 2020.
Share this Video
Related Videos In Chronic Cough
Peter Dicpinigaitis, ERS 2021: Unmet Needs and Advances in Chronic Cough
TouchRESPIRATORY got the opportunity to catch up with Professor Peter Dicpinigaitis (Albert Einstein College of Medicine and Montefiore Cough Center, NY, USA) to learn more about the unmet needs in chronic cough and recent clinical advances. Questions What are the unmet needs in the treatment of patients with refractory or unexplained chronic cough (RCC or […]
Peter Dicpinigaitis, ERS 2021: Gefapixant for Chronic Cough
It was a pleasure to meet with Professor Peter Dicpinigaitis (Albert Einstein College of Medicine and Montefiore Cough Center, NY, USA) to discuss the findings from the COUGH-1 and COUGH-2 studies, investigating gefapixant for the treatment of patients with chronic cough. The abstract ‘Patient-reported chronic cough severity over 52 weeks in two phase 3 trials […]
Jacky Smith, ATS 2021: Findings from the COUGH-1 and COUGH-2 Study Data
We were delighted to talk with Professor Jacky Smith (School of Biological Sciences, The University of Manchester, Manchester, UK) around cough frequency with gefapixant in patients with chronic cough. The abstract ‘Objective Cough Frequency with Gefapixant in Chronic Cough: A Pooled Analysis of Two Phase 3 Randomized, Controlled Clinical Trials (COUGH-1 and COUGH-2).’ was presented […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!